In the fight against Ebola, there is a breakthrough. An international team of researchers has developed a new vaccine which is considered safe. Still, the Tests continue, but current developments give reason for hope.
Scientists have classified in accordance with the first Tests of a vaccine against Ebola to be safe. The “safety profile” of the British group GlaxoSmithKline and the U.S. institutes of health-developed material was as hoped for, it was said in the published on Wednesday the results of the study. They are published in the journal “New England Journal of Medicine”.
The results are based on tests with 60 healthy volunteers were vaccinated between September and November. The substances in all three phases, has to go through a potential vaccine, had been considered safe, was the name of it now. The subjects to a total of six months after the vaccinations were observed.
Almost 9000 deaths caused by Ebola
The tested vaccine contains no infectious Ebola virus, a disease of the healthy study participants is excluded. The head of the investigation, which takes place at the UK’s University of Oxford, Adrian Hill, of the language, however, of the “mild symptoms” that can occur in the first days after vaccination. Within 28 days after vaccination, the subjects had antibody would be formed.
According to the UN, nearly 9,000 people have died since the Ebola outbreak about a year ago – almost all of the deaths were reported in the three West African countries of Liberia, Guinea and Sierra Leone. So far, there is still no approved vaccine against Ebola.